Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focus on olanzapine.

B Green1

  • 1University Department of Psychiatry, Royal Liverpool University Hospital, University of Liverpool, UK. bengreen@liverpool.ac.uk

Current Medical Research and Opinion
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic stress disorder cases reported by UK occupational physicians 1996-2024.

Occupational medicine (Oxford, England)·2026
Same author

Spinal Epidural Abscess Without Fever: Challenging the Classic Triad.

Irish medical journal·2024
Same author

Comparison of the survival of different isolates of SARS-CoV-2 in evaporating aerosols.

Aerosol science and technology : the journal of the American Association for Aerosol Research·2023
Same author

Pulse- and field-resolved THz-diagnostics at 4 <sup></sup> generation lightsources.

Optics express·2019
Same author

Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

Scientific reports·2019
Same author

On-chip THz spectrometer for bunch compression fingerprinting at fourth-generation light sources.

Journal of synchrotron radiation·2018
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
Same journal

Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

Current medical research and opinion·2026
See all related articles

Olanzapine, an atypical antipsychotic, shows efficacy comparable or superior to haloperidol and risperidone. Its favorable side-effect profile, with common somnolence and weight gain, suggests a major role in managing psychotic disorders.

Area of Science:

  • Pharmacology
  • Psychiatry

Background:

  • Olanzapine is a novel antipsychotic from the theinobenzodiazepine class.
  • It exhibits pleiotropic pharmacology, impacting dopaminergic, serotonergic, muscarinic, and adrenergic systems.
  • Atypical antipsychotics offer therapeutic advantages due to additional serotonergic effects.

Purpose of the Study:

  • To evaluate the efficacy and side-effect profile of olanzapine.
  • To compare olanzapine with existing antipsychotics like haloperidol and risperidone.
  • To assess olanzapine's potential as a first-line treatment for psychotic disorders.

Main Methods:

  • Clinical studies and trials were conducted to assess olanzapine's performance.
  • Efficacy and side-effect profiles were compared against haloperidol and risperidone.

Related Experiment Videos

  • Pharmacokinetic data including peak plasma levels and half-life were analyzed.

    • Main Results:

    • Olanzapine demonstrated comparable or superior efficacy to haloperidol and potentially risperidone.
    • Common side-effects include somnolence and weight gain (approx. 40% of patients).
    • Olanzapine is less likely to cause sexual dysfunction compared to other antipsychotics.

    Conclusions:

    • Olanzapine presents a favorable efficacy and side-effect profile for managing psychotic disorders.
    • The drug is unlikely to cause QTc interval abnormalities, negating the need for baseline ECG.
    • Olanzapine is positioned as a significant option for first-line treatment of psychosis.